Delivery Order SPE2DB22D3501-SPE2DB25FTE20

Award Date 10/16/24
Potential Completion Date 11/6/24
Potential Value $44K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $110,408.40 firm-fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has an ultimate completion date of August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the...
This is a firm fixed-price delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Darzalex Faspro, a specialty medication, with a ceiling value of $59,802.10 and a performance period through February 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $64,413.24 firm-fixed-price delivery order is to provide DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 16, 2024. This award is a task order under Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $198,735.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp. This contract is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The award has an ultimate completion date of August 19, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 firm fixed-price delivery order is for the supply of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract has an ultimate completion date of December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $176,653.44, is for the supply of the specialty pharmaceutical DARZALEX FASPRO. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a...
This is a $85,884.32 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DARZALEX FASPRO, a specialty medication, with a period of performance through May 10, 2023. This award is under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a $35,881.26 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 30,000 units of the specialty drug DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 3, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $55,204.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Darzalex Faspro, a specialty medication, with an ultimate completion date of October 28, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for the supply of a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FTE20
    Delivery Order

This contract award to AmerisourceBergen Drug Corp is for the delivery of Darzalex Faspro, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $44,163.36 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. The award supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism for essential pharmaceutical and medical commodities.

Generated 1/15/25, 9:33 AM